Bill117th CongressFiled Mar 9, 2022Health
H.R. 7035
Biologics Market Transparency Act of 2022
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Mar 9, 2022)
Biologics Market Transparency Act of 2022
This bill requires biologics manufacturers to notify the Food and Drug Administration in advance of withdrawing a product from sale.
What just happenedMar 10, 2022
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Manning, Kathy E. [D-NC-6](D-NC)Sponsor
1 cosponsor1 R
1cosponsors1committees4actions3related bills
- Introduced in HouseMar 9, 2022
- Mar 10, 2022Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Mar 9, 2022IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Mar 9, 2022IntroReferralIntro-H
Introduced in House
- Mar 9, 2022IntroReferral1000
Introduced in House